rais near- long-term outlook appear bright
morn baxter report result ahead street top
bottom-lin provid full-year guidanc ahead expect second
quarter row advanc surgeri standout solid
result medic deliveri certainli take risk stori tabl
think manag decis rais guidanc today reflect posit momentum
busi near-term think home dialysi execut order
final could provid meaning tailwind bax renal busi long-term
addit manag downplay opportun junctur expect
share repurchas continu push share higher come quarter consequ
reiter ow rate rais pt
result report sale oper ahead street
driven out-performance advanc surgeri pharmaceut
segment gross margin miss target slightli due cyclo brevibloc
unfavor product mix tighter cost control sg effici
project drove nice bp oper margin beat continu aggress
repurchas share quarter plan continu financi
attract opportun appear scarc moment collect factor
yield ep beat target eight cent
guidanc manag rais full-year top-line guidanc constant
currenc report versu street bottom line continu
expect bp oper margin expans despit one-tim cost headwind
associ dialysi relat recal lower overal tax rate drive ep
cent higher year new guidanc versu prior
third quarter outlook manag guid revenu growth report
oper versu street expect ep
point call call provid mani import posit updat
busi execut order sign presid trump could provid
meaning tailwind bax heavili pd focus renal busi rule final
later year manag expect invest significantli increas
product capac home dialysi product estim could doubl
incid patient use home dialysi period potenti someth
neighborhood year near-term experienc
manufactur capac challeng revaclear line expect increment
spend build capac continu confid direct
segment continu page
price pressur gener competit deal execut
ebitda
assum net debt s/o
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
point call continu importantli absorb cost
associ recal year maintain outlook bp oper margin
expans year consequ cost go away next year provid
signific om tailwind medic deliveri busi though fell short street
expect in-lin manag expect slow tough comp
compani reiter growth outlook year sever new product come
easier comp quarter result eas fear investor get
target busi continu key growth driver
compani benefit sever new product launch includ approv
myxredlin insulin given valuat med-tech near-term transform appear
unlik though compani continu invest base busi return cash
stock share trade higher today follow strong print
rais full-year outlook signal confid busi trend right
direct continu believ manag team proven abil meet
expect believ said done addit think
home dialysi push could provid meaning tailwind intermediate-term allow
share push higher consequ reiter ow rate rais pt
multipl ebitda assum net debt
s/o given improv secular busi trend renal med deliveri
page
factset pjc estim
page
market incom expens net net incom analysi gross market oper analysi total hospit
million
sale
market administr
adj dilut ep discontinu op
revenu report
percent sale
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
